Outcomes of patients with peripheral t-cell lymphoma in first complete remission: Data from three tertiary asian cancer centers

• Main Authors: Tang, T, Khoo, L.P, Lim, C, Ham, J.S, Kim, S.J, Hong, H, Phipps, C, Lee, Y.S, Tao, M, Quek, R, Farid, M, Lin, T, Kim, W.S, Lim, S.T
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Letter
• Published: Nature Publishing Group 2020
• Subjects: alemtuzumab; anthracycline; carboplatin; cisplatin; cytarabine; etoposide; gemcitabine; ifosfamide; methotrexate; procarbazine; steroid; vincristine; antineoplastic agent; adolescent; adult; aged; allogeneic stem cell transplantation; anaplastic large cell lymphoma; angioimmunoblastic t cell lymphoma; cancer center; cancer combination chemotherapy; cancer patient; cancer prognosis; cancer regression; cancer survival; cancer therapy; clinical outcome; cohort analysis; comparative study; controlled study; drug megadose; female; human; International Prognostic Index; intestine lymphoma; Letter; major clinical study; male; middle aged; monomorphic epitheliotropic intestinal T cell lymphoma; overall survival; peripheral T cell lymphoma; progression free survival; retrospective study; very elderly; Asian continental ancestry group; disease free survival; induction chemotherapy; Kaplan Meier method; mortality; pathology; proportional hazards model; remission; risk factor; treatment outcome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian Continental Ancestry Group; Disease-Free Survival; Female; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Proportional Hazards Models; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/178552
• Institution: National University of Singapore

10.1038/s41408-017-0030-y